
|Articles|April 5, 2004
Lung cancer guidelines revised to include latest drugs
An estimated 173,300 Americans will be diagnosed with lung cancer this year, and 164,440 persons will die of the disease. The five-year survival rate for patients with this condition is only 14%. In an effort to improve these statistics, the National Comprehensive Cancer Network (NCCN) recently revised its Non-Small Cell Lung Cancer Clinical Practice Guidelines. The guidelines update was announced at the NCCN 9th Annual Conference, held last month in Hollywood, Fla.NCCN Clinical Practice Guidelines in Oncology are available free-of-charge on CD-ROM. They can be ordered directly from NCCN by calling 215-690-0300. The guidelines are also available on the NCCN Web site at http://www.nccn.org.
Advertisement
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Long-Term Adverse Effects After COVID-19 Vaccination Vary by Brand
2
Hormone Replacement Therapy May Lower Dementia Risk in Postmenopausal Women
3
Model Finds Weight Regain After Stopping Semaglutide or Tirzepatide
4
AI, Automation Are Transforming Pharmacies into Proactive Care Hubs
5







































